Clinical Presentation, Management, and Prognosis of Pseudogout in Joint Arthroplasty: A Retrospective Cohort Study

<p class="p p-first" id="__p2"><strong>Introduction:</strong> Calcium pyrophosphate deposition disease (CPPD), or pseudogout, is rare in prosthetic joints, but can mimic prosthetic joint infection (PJI) according to case reports. The purpose of this case series...

Full description

Bibliographic Details
Main Authors: M. P. George, F. C. Ernste, A. Tande, D. Osmon, T. Mabry, E. F. Berbari
Format: Article
Language:English
Published: Copernicus Publications 2019-01-01
Series:Journal of Bone and Joint Infection
Online Access:https://jbji.copernicus.org/articles/4/20/2019/jbji-4-20-2019.pdf
id doaj-7027c4a3e20d4fe7be219535f5a34ea4
record_format Article
spelling doaj-7027c4a3e20d4fe7be219535f5a34ea42021-03-03T14:43:51ZengCopernicus PublicationsJournal of Bone and Joint Infection2206-35522019-01-014202610.7150/jbji.29983Clinical Presentation, Management, and Prognosis of Pseudogout in Joint Arthroplasty: A Retrospective Cohort StudyM. P. George0F. C. Ernste1A. Tande2D. Osmon3T. Mabry4E. F. Berbari5Mayo Clinic School of Medicine. 200 1st St SW, Rochester, MN 55905.Division of Rheumatology, Department of Internal Medicine, Mayo Clinic School of Graduate Medical Education. 200 1st St SW, Rochester, MN 55905.Division of Infectious Diseases, Department of Internal Medicine, Mayo Clinic School of Graduate Medical Education. 200 1st St SW, Rochester, MN 55905.Division of Infectious Diseases, Department of Internal Medicine, Mayo Clinic School of Graduate Medical Education. 200 1st St SW, Rochester, MN 55905.Division of Orthopedic Surgery, Department of Surgery, Mayo Clinic School of Graduate Medical Education. 200 1st St SW, Rochester, MN 55905Division of Infectious Diseases, Department of Internal Medicine, Mayo Clinic School of Graduate Medical Education. 200 1st St SW, Rochester, MN 55905.<p class="p p-first" id="__p2"><strong>Introduction:</strong> Calcium pyrophosphate deposition disease (CPPD), or pseudogout, is rare in prosthetic joints, but can mimic prosthetic joint infection (PJI) according to case reports. The purpose of this case series is to describe the demographics, presentation, management, and outcomes of a cohort of these patients seen at our academic medical center.</p><p id="__p3"><strong>Methods:</strong> Patients with post-implant pseudogout, who were evaluated at our medical center between January 1, 2000 and June 30, 2016, were identified from our EHR. Data pertaining to demographics, presentation, management, and outcomes were abstracted, and patients were categorized into two groups based on presence of concomitant infection along with positive CPDD findings in synovial fluid.</p><p id="__p4"><strong>Results:</strong> 22 patients were included. 90.9% of cases involved a TKA. The most common indication for arthroplasty was degenerative joint disease. Only four patients had a history of previous gout or pseudogout, three of which belonged to the group with no evidence of concomitant joint infection. Clinical features for patients without concomitant infection included pain (100%), swelling at the joint (88.9%), redness (33.3%), fever (22.2%), and decreased range of motion (100%). 45.5% of patients received antibiotics prior to joint aspiration (44.4% of patients with negative synovial fluid cultures, 46.2% of patients with concomitant infection).</p><p class="p p-last" id="__p5"><strong>Conclusion:</strong> Our study suggests similar clinical presentation between post-implant pseudogout and PJI. Among patients with pseudogout as well as in those with PJI, the first dose of antibiotics should not be given before sampling for synovial culture. Unfortunately, many patients receive antibiotics prior to culture ascertainment, which raises concern for antibiotic overuse.</p>https://jbji.copernicus.org/articles/4/20/2019/jbji-4-20-2019.pdf
collection DOAJ
language English
format Article
sources DOAJ
author M. P. George
F. C. Ernste
A. Tande
D. Osmon
T. Mabry
E. F. Berbari
spellingShingle M. P. George
F. C. Ernste
A. Tande
D. Osmon
T. Mabry
E. F. Berbari
Clinical Presentation, Management, and Prognosis of Pseudogout in Joint Arthroplasty: A Retrospective Cohort Study
Journal of Bone and Joint Infection
author_facet M. P. George
F. C. Ernste
A. Tande
D. Osmon
T. Mabry
E. F. Berbari
author_sort M. P. George
title Clinical Presentation, Management, and Prognosis of Pseudogout in Joint Arthroplasty: A Retrospective Cohort Study
title_short Clinical Presentation, Management, and Prognosis of Pseudogout in Joint Arthroplasty: A Retrospective Cohort Study
title_full Clinical Presentation, Management, and Prognosis of Pseudogout in Joint Arthroplasty: A Retrospective Cohort Study
title_fullStr Clinical Presentation, Management, and Prognosis of Pseudogout in Joint Arthroplasty: A Retrospective Cohort Study
title_full_unstemmed Clinical Presentation, Management, and Prognosis of Pseudogout in Joint Arthroplasty: A Retrospective Cohort Study
title_sort clinical presentation, management, and prognosis of pseudogout in joint arthroplasty: a retrospective cohort study
publisher Copernicus Publications
series Journal of Bone and Joint Infection
issn 2206-3552
publishDate 2019-01-01
description <p class="p p-first" id="__p2"><strong>Introduction:</strong> Calcium pyrophosphate deposition disease (CPPD), or pseudogout, is rare in prosthetic joints, but can mimic prosthetic joint infection (PJI) according to case reports. The purpose of this case series is to describe the demographics, presentation, management, and outcomes of a cohort of these patients seen at our academic medical center.</p><p id="__p3"><strong>Methods:</strong> Patients with post-implant pseudogout, who were evaluated at our medical center between January 1, 2000 and June 30, 2016, were identified from our EHR. Data pertaining to demographics, presentation, management, and outcomes were abstracted, and patients were categorized into two groups based on presence of concomitant infection along with positive CPDD findings in synovial fluid.</p><p id="__p4"><strong>Results:</strong> 22 patients were included. 90.9% of cases involved a TKA. The most common indication for arthroplasty was degenerative joint disease. Only four patients had a history of previous gout or pseudogout, three of which belonged to the group with no evidence of concomitant joint infection. Clinical features for patients without concomitant infection included pain (100%), swelling at the joint (88.9%), redness (33.3%), fever (22.2%), and decreased range of motion (100%). 45.5% of patients received antibiotics prior to joint aspiration (44.4% of patients with negative synovial fluid cultures, 46.2% of patients with concomitant infection).</p><p class="p p-last" id="__p5"><strong>Conclusion:</strong> Our study suggests similar clinical presentation between post-implant pseudogout and PJI. Among patients with pseudogout as well as in those with PJI, the first dose of antibiotics should not be given before sampling for synovial culture. Unfortunately, many patients receive antibiotics prior to culture ascertainment, which raises concern for antibiotic overuse.</p>
url https://jbji.copernicus.org/articles/4/20/2019/jbji-4-20-2019.pdf
work_keys_str_mv AT mpgeorge clinicalpresentationmanagementandprognosisofpseudogoutinjointarthroplastyaretrospectivecohortstudy
AT fcernste clinicalpresentationmanagementandprognosisofpseudogoutinjointarthroplastyaretrospectivecohortstudy
AT atande clinicalpresentationmanagementandprognosisofpseudogoutinjointarthroplastyaretrospectivecohortstudy
AT dosmon clinicalpresentationmanagementandprognosisofpseudogoutinjointarthroplastyaretrospectivecohortstudy
AT tmabry clinicalpresentationmanagementandprognosisofpseudogoutinjointarthroplastyaretrospectivecohortstudy
AT efberbari clinicalpresentationmanagementandprognosisofpseudogoutinjointarthroplastyaretrospectivecohortstudy
_version_ 1724232793675792384